Italiano
About CTI
About CTI - Management
About CTI - Board of Directors
About CTI - In the Community
Partnering with CTI
Clinical Development
Pixantrone (PIXUVRI®)
Pacritinib
Tosedostat
Paclitaxel poliglumex (Opaxio™)
Brostallicin
Medical Presentations & Publications
Medical Inquiries for Healthcare Professionals
Medical Inquiries for Patients and Caregivers
Media
News
Investors
News
Stock
SEC Filings
Analyst Coverage
Presentations & Webcasts
Annual Reports
Financial Details
Corporate Governance
Investor FAQ
Information Request
Email Alerts
Careers
Benefits
Job Opportunities
Contact CTI
Directions
Definition
Tweet
<<
Back
Price to Book (MRQ)
This is the Current Price divided by the latest interim period Book Value Per Share.
News
Stock
SEC Filings
Analyst Coverage
Presentations & Webcasts
Annual Reports
Financial Details
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Corporate Governance
Investor FAQ
Information Request
Email Alerts
Info Tools
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
IR Contacts
Tear Sheet
Most Viewed Links
1.
German Federal Joint Committee (G-BA) Issues Final Assessment Report for PIXUVRI® (pixantrone)
2.
SEC Filings
3.
Company Presentations & Webcasts
4.
Stock Quote
5.
Cell Therapeutics to Present at Upcoming Investor Conferences
You are now leaving this website. If you would like to continue, click Continue.
Cancel
Continue
